Forbes January 21, 2021
It’s not a secret that finally, after years of being overlooked, women’s health is having its moment. According to Frost & Sullivan’s report, the femtech (female technology) market revenue is expected to reach $1.1 billion by 2024, growing at a compound annual growth rate (CAGR) of 12.9%. The report states that, through solutions targeting early diagnosis and leveraging connected healthcare services, these technologies can reduce healthcare costs, decreasing the overall cost burden of a country while elevating healthcare standards and quality of life for women. But it took a long time for female healthcare to be where it is today.
Ever since the FDA (The United States Food and Drug Administration) in 1977 issued a guideline banning most women...